Live from the NIH registry
Studies recruiting near Victorville right now
Top 25 of 54 recruiting studies, sorted by proximity — each links to its official registry page
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate
Phase 2
Interventional 1,431 participants sought
Om Research LLC — Victorville, California (3.6 mi)
· Sponsor: Eli Lilly and Company
A Study to Test How BI 1291583 is Taken up in the Blood of People With and Without Liver Problems
Healthy, Hepatic Impairment
Phase 1
Interventional 32 participants sought
Inland Empire Clinical Trials, LLC — Rialto, California (29.1 mi)
· Sponsor: Boehringer Ingelheim
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
Metabolic Dysfunction Associated Steatohepatitis
Phase 3
Interventional 1,590 participants sought
Inland Empire Clinical Trials, LLC — Rialto, California (29.1 mi)
· Sponsor: Boehringer Ingelheim
A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Patients (AUTOGRAPH - SLE/LN)
Lupus Erythematosus, Systemic, Lupus Nephritis
Phase 2
Interventional 179 participants sought
Loma Linda University — San Bernardino, California (29.2 mi)
· Sponsor: Novartis Pharmaceuticals
Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes
Diabetes Mellitus, Type 1
Phase 3
Interventional 150 participants sought
Velocity Clinical Research — San Bernardino, California (29.2 mi)
· Sponsor: vTv Therapeutics
Study to Assess the Effects of Angiopoietin-like Protein 3 (ANGPTL3) Inhibition in Adult Participants With Diabetic Kidney Disease
Diabetic Kidney Disease (DKD)
Phase 2
Interventional 270 participants sought
National Institute of Clinical Research, Inc. — Victorville, California (3.6 mi)
· Sponsor: Regeneron Pharmaceuticals
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
End Stage Kidney Disease
Phase 2, Phase 3
Interventional 3,110 participants sought
National Institute of Clinical Research, Inc — Victorville, California (3.6 mi)
· Sponsor: CSL Behring
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Ulcerative Colitis
Phase 3
Interventional 980 participants sought
Om Research, LLC - Victorville - Site Number: 8400022 — Victorville, California (3.6 mi)
· Sponsor: Sanofi
A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)
Staphylococcus Aureus
Phase 1, Phase 2
Interventional 231 participants sought
Research Site — Victorville, California (3.6 mi)
· Sponsor: AstraZeneca
A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)
Immunoglobulin A Nephropathy (IgAN)
Phase 3
Interventional 454 participants sought
Kidney & Hypertension Center - Apple Valley — Apple Valley, California (9.7 mi)
· Sponsor: Biogen
Lateral Pharyngoplasty Outcomes in Children Undergoing Tonsillectomy
Sleep-Disordered Breathing, Sleep Apnea Syndromes in Children
N/A
Interventional 160 participants sought
Pediatric Ear, Nose, and Throat Surgery and Audiology — San Bernardino, California (29.2 mi)
· Sponsor: Loma Linda University
A Phase I Study to Investigate the Pharmacokinetics and Safety of Capivasertib in Participants With Moderate Hepatic Impairment
Moderate Hepatic Impairment
Phase 1
Interventional 20 participants sought
Research Site — Rialto, California (29.1 mi)
· Sponsor: AstraZeneca
A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
Prostate Cancer
Phase 2
Interventional 900 participants sought
Site US10008 — San Bernardino, California (29.2 mi)
· Sponsor: Astellas Pharma Global Development, Inc.
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis
Moderately to Severely Active Ulcerative Colitis
Phase 3
Interventional 350 participants sought
Om Research LLC — Apple Valley, California (9.7 mi)
· Sponsor: Hoffmann-La Roche
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
Ulcerative Colitis, Ulcerative Colitis Chronic
Phase 2
Interventional 143 participants sought
Om Research LLC — Victorville, California (3.6 mi)
· Sponsor: Eli Lilly and Company
A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older
Clostridoides Difficile Associated Disease
Phase 3
Interventional 32,500 participants sought
Velocity Clinical Research, San Bernardino — San Bernardino, California (29.2 mi)
· Sponsor: Pfizer
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
Metabolic Dysfunction-Associated SteatoHepatitis (MASH)
Phase 2
Interventional 120 participants sought
Inland Empire Liver Foundation — Rialto, California (29.1 mi)
· Sponsor: Regeneron Pharmaceuticals
A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
Metabolic Dysfunction-Associated Steatohepatitis, Non-alcoholic Fatty Liver Disease
Phase 2
Interventional 42 participants sought
GSK Investigational Site — Rialto, California (29.1 mi)
· Sponsor: GlaxoSmithKline
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
Acute Treatment of Migraine
Phase 3
Interventional 600 participants sought
Velocity Clinical Research- Banning — San Bernardino, California (29.2 mi)
· Sponsor: Pfizer
Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
Lupus Nephritis
Phase 2
Interventional 240 participants sought
Loma Linda University — San Bernardino, California (29.2 mi)
· Sponsor: Novartis Pharmaceuticals
A Study Evaluating the Efficacy and Safety of ALG-000184 Compared With Tenofovir Disoproxil Fumarate in Untreated HBeAg-Positive and HBeAg- Negative Adult Subjects With Chronic Hepatitis B (B-SUPREME)
Chronic Hepatitis B Infection
Phase 2
Interventional 200 participants sought
Aligos Investigational Site — Rialto, California (29.1 mi)
· Sponsor: Aligos Therapeutics
A Phase I Study to Investigate the Effect of Hepatic Impairment of AZD9550 and AZD6234
Hepatic Impairment
Phase 1
Interventional 28 participants sought
Research Site — Rialto, California (29.1 mi)
· Sponsor: AstraZeneca
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
Metabolic Dysfunction-associated Steatohepatitis
Phase 2
Interventional 160 participants sought
Om Research — Victorville, California (3.6 mi)
· Sponsor: Eccogene
A Study of Dotinurad Versus Allopurinol in Participants With Gout
Gout
Phase 3
Interventional 500 participants sought
Velocity Clinical Research - San Bernardino — San Bernardino, California (29.2 mi)
· Sponsor: Crystalys Therapeutics
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy
Diabetic Peripheral Neuropathic Pain
Phase 3
Interventional 1,100 participants sought
Velocity Clinical Research, San Bernardino — San Bernardino, California (29.2 mi)
· Sponsor: Vertex Pharmaceuticals Incorporated